These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7709711

  • 1. [Can vasomotion be modified by vasoactive substances or hemodilution?].
    Tischler R, Decrinis M, Skursky-Roller R.
    Acta Med Austriaca; 1994; 21(5):133-6. PubMed ID: 7709711
    [Abstract] [Full Text] [Related]

  • 2. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J, Intaglietta M, Messmer K.
    Fortschr Med; 1982 Nov 04; 100(41):1926-30. PubMed ID: 7152426
    [Abstract] [Full Text] [Related]

  • 3. Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease.
    Milio G, Cospite V, Cospite M.
    Minerva Cardioangiol; 2003 Jun 04; 51(3):311-6. PubMed ID: 12867883
    [Abstract] [Full Text] [Related]

  • 4. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F, Perbellini A, Adami CA, Dal Cortivo G, Bucci S.
    Clin Ter; 1986 Dec 15; 119(5):379-85. PubMed ID: 2951055
    [No Abstract] [Full Text] [Related]

  • 5. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
    Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R.
    J Int Med Res; 1985 Dec 15; 13(6):317-21. PubMed ID: 4076530
    [Abstract] [Full Text] [Related]

  • 6. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A, Rieger H.
    Z Arztl Fortbild Qualitatssich; 1999 Nov 15; 93(9):639-44. PubMed ID: 10666827
    [Abstract] [Full Text] [Related]

  • 7. The effect of prostaglandin E1 on nailfold capillary blood pressure and red blood cell velocity in humans.
    Hahn M, Jünger M, Shore AC.
    Clin Hemorheol Microcirc; 2004 Nov 15; 31(3):227-34. PubMed ID: 15322328
    [Abstract] [Full Text] [Related]

  • 8. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S, Manganaro A, Barbera MC, Cento D, Buda D, Arrigo F, Consolo F.
    Minerva Cardioangiol; 1986 Nov 15; 34(11):745-9. PubMed ID: 2949163
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V.
    Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536
    [No Abstract] [Full Text] [Related]

  • 10. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G, Rotatori P, Gaggi S, Barone A, Pupita F.
    Minerva Cardioangiol; 1988 Jun 30; 36(6):319-22. PubMed ID: 3211330
    [No Abstract] [Full Text] [Related]

  • 11. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S, Ferulano GP, Vanni L, Dilillo S, Picilli M, D'Alessio E.
    Minerva Cardioangiol; 1985 Nov 30; 33(11):749-56. PubMed ID: 2935748
    [No Abstract] [Full Text] [Related]

  • 12. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):41. PubMed ID: 14974333
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Dec 18; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 14. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G.
    Vasa Suppl; 1988 Dec 18; 23():121-5. PubMed ID: 3206330
    [No Abstract] [Full Text] [Related]

  • 15. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]

  • 16. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P, Birkel L, Grub KR, de la Hamette D.
    Vasa Suppl; 1988 Mar 02; 23():126-9. PubMed ID: 3061035
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of coronary blood flow during exercise.
    Duncker DJ, Bache RJ.
    Physiol Rev; 2008 Jul 02; 88(3):1009-86. PubMed ID: 18626066
    [Abstract] [Full Text] [Related]

  • 18. [MR-Imaging of lower leg muscle perfusion].
    Leppek R, Hoos O, Sattler A, Kohle S, Azzam S, Al Haffar I, Keil B, Ricken P, Klose KJ, Alfke H.
    Herz; 2004 Feb 02; 29(1):32-46. PubMed ID: 14968340
    [Abstract] [Full Text] [Related]

  • 19. The influence of Emla cream on cutaneous microcirculation.
    Häfner HM, Thomma SR, Eichner M, Steins A, Jünger M.
    Clin Hemorheol Microcirc; 2003 Feb 02; 28(3):121-8. PubMed ID: 12775894
    [Abstract] [Full Text] [Related]

  • 20. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM, Ardita G, Giani L, Mugno F, Stevenazzi F, Mazzone A.
    Minerva Cardioangiol; 2006 Jun 02; 54(3):377-81. PubMed ID: 16733512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.